Staar Surgical (STAA) FY2017 results: revenue $91 million, up 9.9% on the year
Staar Surgical Co. (STAA) reported revenue of $91 million for fiscal 2017, the year ended 29 December 2017, up 9.9% on the year before. Net income was -$2 million, and diluted earnings per share $-0.05. The figures are the company's own, from the 10-K it filed with the SEC on 21 February 2019.
Revenue
$91 million
+9.9% on the year
FY2010FY2017
Operating margin
-4.0%
-15.4% a year earlier
FY2010FY2017
Net income
-$2 million
FY2010FY2017
Diluted EPS
-$0.05
FY2010FY2017
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2017
FY2016
FY2015
On the year
Last 8 years
Revenue
90.6
82.4
77.1
+9.9%
Cost of revenue
26.3
24.1
24.4
+9.4%
Gross profit
64.3
58.4
52.7
+10.1%
Gross margin
70.9%
70.8%
68.4%
Research and development
20.0
20.7
14.8
-3.0%
Selling, general and administrative
67.9
71.0
n/a
-4.4%
Operating income
-3.6
-12.7
-5.3
Operating margin
-4.0%
-15.4%
-6.9%
Interest expense
0.1
0.1
0.1
0.0%
Pre-tax income
-2.3
-12.4
-5.6
Income tax
-0.2
-0.3
0.9
Net income
-2.1
-12.1
-6.5
Net margin
-2.4%
-14.7%
-8.5%
Diluted EPS
-$0.05
-$0.30
-$0.17
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2017
FY2016
FY2015
On the year
Last 8 years
Operating cash flow
2.9
1.0
-2.2
+172.0%
Capital expenditure
1.0
3.2
2.0
-67.4%
Free cash flow
1.8
-2.2
-4.2
Free cash flow margin
2.0%
-2.6%
-5.5%
Cash from investing
-1.0
-3.2
-2.0
Cash from financing
2.4
3.0
4.6
-17.5%
Depreciation and amortisation
3.4
2.9
2.4
+16.0%
Share-based compensation
3.2
8.6
3.3
-63.1%
Diluted shares, weighted
41m
40m
39m
+1.7%
Shares outstanding at period end
41m
41m
40m
+1.6%
Balance sheet
$ million
FY2017
FY2016
FY2015
On the year
Last 8 years
Shareholders' equity
42.9
37.9
38.8
+13.3%
Debt
4.4
4.3
4.2
+3.6%
Other liabilities
20.6
23.3
19.9
-11.6%
Total liabilities and equity
67.9
65.4
63.0
+3.8%
Fixed assets
9.8
11.8
10.1
-17.1%
Goodwill
1.8
1.8
1.8
0.0%
Intangible assets
0.3
0.5
0.7
-42.7%
Cash and equivalents
18.5
14.0
13.4
+32.3%
Receivables
17.9
16.3
15.7
+9.2%
Inventory
n/a
n/a
15.9
Other assets
19.7
21.1
5.4
-6.3%
Total assets
67.9
65.4
63.0
+3.8%
10-K for the year ended 29 December 2017, filed 21 February 2019: the filing.